Rigel Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Cover
- DOCUMENT AND ENTITY INFORMATION
Financial Statements
Notes to Financial Statements
Accounting Policies
- DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
Notes Tables
Notes Details

OTHER BALANCE SHEET COMPONENTS (Tables)

v3.22.4

OTHER BALANCE SHEET COMPONENTS (Tables)

12 Months Ended

Dec. 31, 2022

OTHER BALANCE SHEET COMPONENTS

Schedule of property and equipment

Property and equipment

Property and equipment consist of the following (in thousands):


	As of December 31,
	2022		2021
Laboratory equipment	$	7,435	$	12,154
Computer and software		2,048		1,783
Furniture and equipment		2,107		2,107
Fixed assets in progress		74		691
Total property and equipment		11,664		16,735
Less accumulated depreciation and amortization		(10,807)		(14,551)
Property and equipment, net	$	857	$	2,184

Schedule of estimated future amortization expense of intangible asset

The following table presents the estimated future amortization expense of intangible asset (in thousands):


For the year ending December 31,
2023	$	1,071
2024		1,071
2025		1,071
2026		1,071
2027		1,071
Thereafter		9,594
	$	14,949

Schedule of other accrued liabilities

Other accrued liabilities consist of the following (in thousands):


	As of December 31,
	2022		2021
Accrued commercial expenses	$	3,144	$	1,949
Accrued other expenses		3,341		2,827
Total other accrued liabilities	$	6,485	$	4,776

- References

No definition available.

+ Details

Name:	us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

+ Details

Name:	us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

+ Details

Name:	us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration